Among PASE-related genes, cyclin-dependent kinase inhibitor 2A (CDKN2A) showed the most significant upregulation in tumor tissues compared with adjacent normal tissues (|logFC| = 1.38, P< 0.001) (Figure 6A). This evidence concerns the gene CDKN2A and neoplasm.